RBC Capital Markets 2008 Healthcare Conference on December 10, 2008 J.P. Morgan 27th Annual Healthcare Conference on January 15, 2009
SAN MATEO, Calif., Dec. 5, 2008 (GLOBE NEWSWIRE) -- BioForm Medical, Inc. (Nasdaq:BFRM) announced today that the Company will participate at two upcoming investor events.
BioForm Medical SVP, Corporate Development, Adam Gridley, is scheduled to participate in a panel discussion titled "Aesthetic Dermatology" at the RBC Capital Markets 2008 Healthcare Conference on December 10, 2008 at 2:30 p.m. (ET) in New York City.
BioForm Medical is also scheduled to present at the J.P. Morgan 27th Annual Healthcare Conference on January 15, 2009. BioForm Medical Chief Executive Officer Steve Basta is scheduled to provide a corporate overview of the Company at 10:00 a.m. (PT) in San Francisco.
The events will be webcast live on the Investor Relations section of BioForm Medical's website at http://investor.bioform.com/events.cfm. The online archive of the presentations will be available approximately 90 minutes after the live call and will continue to be available for four weeks.
About BioForm Medical, Inc.:
BioForm Medical, Inc. is a medical aesthetics company headquartered in San Mateo, California, developing products that enhance aesthetic procedures performed in dermatology and plastic surgery practices. BioForm Medical's lead product is Radiesse(r) dermal filler, a long-lasting filler for use in facial aesthetics. BioForm Medical is developing several future aesthetics products, including a radiofrequency treatment to reduce nerve function in the forehead, a sclerotherapy treatment for spider veins, and a surgical adhesive for brow lifts. For more information about BioForm, please visit www.bioform.com.